Pseudoprogression and Immune-Related Response in Solid Tumors

J Clin Oncol. 2015 Nov 1;33(31):3541-3. doi: 10.1200/JCO.2015.61.6870. Epub 2015 Aug 10.
No abstract available

MeSH terms

  • Antibodies, Monoclonal / chemistry
  • Antibodies, Monoclonal / therapeutic use
  • Antibodies, Monoclonal, Humanized
  • B7-H1 Antigen / metabolism*
  • Carcinoma, Non-Small-Cell Lung / drug therapy*
  • Carcinoma, Non-Small-Cell Lung / immunology
  • Clinical Trials as Topic
  • Disease Progression
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Immunotherapy / methods
  • Ipilimumab
  • Ligands
  • Lung Neoplasms / drug therapy*
  • Lung Neoplasms / immunology
  • Melanoma / drug therapy
  • Melanoma / immunology
  • Neoplasms / drug therapy*
  • Neoplasms / immunology
  • Programmed Cell Death 1 Receptor / metabolism*
  • Skin Neoplasms / drug therapy
  • Skin Neoplasms / immunology
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • B7-H1 Antigen
  • CD274 protein, human
  • Ipilimumab
  • Ligands
  • PDCD1 protein, human
  • Programmed Cell Death 1 Receptor
  • atezolizumab